Italy
# |
Name |
Gross Profit Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
100.00%
|
Dec. 31, 2023 | USD 9.91 | -0.63% |
|
Italy |
|
2 |
64.55%
|
Dec. 31, 2023 | USD 103.47 | -0.44% |
|
Italy |
|
3 |
53.01%
|
Dec. 31, 2023 | USD 2.04 | 0.60% |
|
Italy |
|
4 |
48.45%
|
Dec. 31, 2023 | USD 53.59 | 1.39% |
|
Italy |
|
5 |
47.95%
|
Dec. 31, 2023 | USD 7.37 | 1.31% |
|
Italy |
|
6 |
43.14%
|
Dec. 31, 2023 | USD 38.13 | 0.20% |
|
Italy |
|
7 |
24.51%
|
Dec. 31, 2023 | USD 19.32 | 1.97% |
|
Italy |
The Biotechnology company in Italy with the highest Gross Profit Margin is Newron Pharmaceuticals S.p.A. (XETRA: NP5.DE) at 100.00%.
The Biotechnology company in Italy with the lowest Gross Profit Margin is Philogen S.p.A. (Milan Stock Exchange: PHIL.MI) at 24.51%.
The top 10 Biotechnology companies in Italy by Gross Profit Margin are Newron Pharmaceuticals S.p.A., DiaSorin S.p.A., ARTERRA BIOSCIENCE, Pharmanutra S.p.A., Franchetti S.p.A., SOL S.p.A. and Philogen S.p.A..
The bottom 10 Biotechnology companies in Italy by Gross Profit Margin are Philogen S.p.A., SOL S.p.A., Franchetti S.p.A., Pharmanutra S.p.A., ARTERRA BIOSCIENCE, DiaSorin S.p.A. and Newron Pharmaceuticals S.p.A..